Senior Medical Director​/Executive Medical Director​/Vice President

Senior Medical Director / Executive Medical Director / Vice President

Character Biosciences | Posted Mar 14

Full-time

Brisbane

Unknown

Character Biosciences is a precision medicine company pioneering targeted therapies for ophthalmology. Our patient data platform integrates genomics with deep, longitudinal clinical and imaging data, enabling us to uncover genetic drivers of disease progression, advance novel therapeutics, and define patient stratification strategies that improve clinical success.

Our interdisciplinary team spans human genetics, clinical science, data science and engineering, and drug discovery and development. We are advancing two programs for Dry Age-related Macular Degeneration (AMD) into the clinic, with additional discovery-stage programs underway.

Founded in 2018, Character has raised capital from leading investors at the intersection of healthcare and technology, including an oversubscribed $110+ million Series B in 2025 co‑led by aMoon and Luma Group, with participation from Bausch + Lomb, Innovation Endeavors, Sanofi Ventures, Catalio Capital Management, S32, KdT Ventures, and Jefferson Life Sciences. We also maintain a multi‑target drug discovery collaboration with Bausch + Lomb to develop innovative precision medicines for AMD.

Sr. Medical Director (or Executive Medical Director or VP of Clinical Development)

CMO

Clinical

Interventional Study

TBD

Jersey City, NJ;
Brisbane, CA; and/or Remote

As the Senior Medical Director (Ophthalmology/Retina), you will serve as the medical and scientific lead overseeing clinical programs to advance development of novel therapeutics for dry AMD. You will design and execute clinical development plans from Phase 1 through Phase 3. You will ensure the highest standards of clinical judgment, quality, and impact across all projects and teams. The ideal candidate brings at least 3 years of substantive retina clinical trial experience with a demonstrable track record of success with meaningful novel retinal therapeutics.

This position reports to the Chief Medical Officer with flexibility for hybrid or remote work, including up to 20% travel to key sites, meetings, and partners. Proximity to the Brisbane, CA or Jersey City, NJ offices preferred.

• Serve as the medical and scientific lead for 1–2 Phase 2 retinal (dry AMD) clinical trials, directly driving protocol development, execution, and analysis.
• Actively participate in the day‑to‑day operational management of ongoing trials, collaborating with clinical operations and CROs to ensure quality and timeline adherence.
• Lead the clinical review, ongoing medical monitoring, and assessment of trial data, patient safety, and protocol deviations; be the primary medical point‑of‑contact for investigative sites.
• Oversee and participate in the resolution of clinical trial issues, including making recommendations for protocol amendments or trial modifications as new data emerges.

• Author, review, and approve clinical trial protocols, informed consent documents, Investigator Brochures, clinical study reports, and other essential study‑related documentation.
• Prepare, review, and contribute to regulatory submissions (e.g., INDs, CTAs, periodic safety reports) and address regulatory authority queries related to retinal programs.
• Support regulatory agency and IRB/EC meetings by preparing briefing materials and presenting medical and scientific rationale for study design and conduct.

• Build and maintain strong relationships with retina Key Opinion Leaders (KOLs) and study investigators; engage them for study design feedback,…